NTRB - NutriBand Inc.

3.89
-0.106   -2.715%

Share volume: 2,630
Last Updated: 04-27-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.04%

PREVIOUS CLOSE
CHG
CHG%
$4.00
-0.11
-0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
43%
Profitability 35%
Dept financing 24%
Liquidity 75%
Performance 48%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-2.99%
1 Month
12.43%
3 Months
-17.23%
6 Months
-49.87%
1 Year
-33.39%
2 Year
13.74%
Key data
Stock price
$3.89
P/E Ratio 
0.00
DAY RANGE
$3.88 - $3.96
EPS 
-$2.68
52 WEEK RANGE
$3.42 - $11.68
52 WEEK CHANGE
-$31.51
MARKET CAP 
75.068 M
YIELD 
N/A
SHARES OUTSTANDING 
12.175 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
04-30-2025
BETA 
1.70
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$4,014
AVERAGE 30 VOLUME 
$6,699
Company detail
CEO: Gareth R. Sheridan
Region: US
Website: nutriband.com
Employees: 10
IPO year: 2018
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is abuse deterrent fentanyl system.

Recent news